Essity announces 6,410 Class A shares were converted to Class B shares in February

Sample article from our Tissue & Hygiene

March 1, 2024 (press release) –

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.

In February, at the request of shareholders, 6,410 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 1,251,072,876.

The total number of registered shares in the company amounts to 702,342,489 of which 60,970,043 are Class A shares and 641,372,446 are Class B shares.

NB: This information is such that Essity must disclose in accordance with the Financial Instruments Trading Act. The information was submitted for publication on February 29, 2024, at 08:00 CET.

* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.

See our dashboard in action - schedule an demo
Jason Irving
Jason Irving
- SVP Enterprise Solutions -

We offer built-to-order tissue & hygiene coverage for our clients. Contact us for a free consultation.

About Us

We deliver market news & information relevant to your business.

We monitor all your market drivers.

We aggregate, curate, filter and map your specific needs.

We deliver the right information to the right person at the right time.

Our Contacts

1990 S Bundy Dr. Suite #380,
Los Angeles, CA 90025

+1 (310) 553 0008

About Cookies On This Site

We collect data, including through use of cookies and similar technology ("cookies") that enchance the online experience. By clicking "I agree", you agree to our cookies, agree to bound by our Terms of Use, and acknowledge our Privacy Policy. For more information on our data practices and how to exercise your privacy rights, please see our Privacy Policy.